Zoekresultaten - Teerlink, John
- Toon 1 - 20 resultaten van 81
- Ga naar de volgende pagina
-
1
A novel approach to improve cardiac performance: cardiac myosin activators door Teerlink, John R.
Gepubliceerd in 2009Text -
2
-
3
-
4
Acute Decompensated Heart Failure Update door Teerlink, John R, Alburikan, Khalid, Metra, Marco, Rodgers, Jo E
Gepubliceerd in 2015Text -
5
-
6
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond door Teerlink, John R., Metra, Marco, Zacà, Valerio, Sabbah, Hani N., Cotter, Gadi, Gheorghiade, Mihai, Cas, Livio Dei
Gepubliceerd in 2009Text -
7
-
8
-
9
-
10
Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication door Lewis, Roger J, Connor, Jason T, Teerlink, John R, Murphy, James R, Cooper, Leslie T, Hiatt, William R, Brass, Eric P
Gepubliceerd in 2011Text -
11
-
12
Relaxin, a pleiotropic vasodilator for the treatment of heart failure door Teichman, Sam L., Unemori, Elaine, Dschietzig, Thomas, Conrad, Kirk, Voors, Adriaan A., Teerlink, John R., Felker, G. Michael, Metra, Marco, Cotter, Gad
Gepubliceerd in 2008Text -
13
-
14
Incorporating development of a patient-reported outcome instrument in a clinical drug development program: examples from a heart failure program door Wiklund, Ingela, Anatchkova, Milena, Oko-Osi, Hafiz, von Maltzahn, Robyn, Chau, Dina, Malik, Fady I., Patrick, Donald L., Spertus, John, Teerlink, John R.
Gepubliceerd in 2016Text -
15
Reassessing the Role of Surrogate Endpoints in Drug Development for Heart Failure door Greene, Stephen J., Mentz, Robert J., Fiuzat, Mona, Butler, Javed, Solomon, Scott D., Ambrosy, Andrew P., Mehta, Cyrus, Teerlink, John R., Zannad, Faiez, O’Connor, Christopher M.
Gepubliceerd in 2018Text -
16
Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study door Metra, Marco, Teerlink, John R., Felker, G. Michael, Greenberg, Barry H., Filippatos, Gerasimos, Ponikowski, Piotr, Teichman, Sam L., Unemori, Elaine, Voors, Adriaan A., Weatherley, Beth Davison, Cotter, Gad
Gepubliceerd in 2010Text -
17
Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial door Mentz, Robert J, Velazquez, Eric J, Metra, Marco, McKendry, Colleen, Chiswell, Karen, Fiuzat, Mona, Givertz, Michael M, Voors, Adriaan A, Teerlink, John R, O'Connor, Christopher M
Gepubliceerd in 2015Text -
18
Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure: Results From the COSMIC-HF Study door Felker, G. Michael, Solomon, Scott D., McMurray, John J.V., Cleland, John G.F., Abbasi, Siddique A., Malik, Fady I., Zhang, Hanze, Globe, Gary, Teerlink, John R.
Gepubliceerd in 2020Text -
19
Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND‐HF... door Verma, Amanda K., Sun, Jie‐Lena, Hernandez, Adrian, Teerlink, John R., Schulte, Phillip J., Ezekowitz, Justin, Voors, Adriaan, Starling, Randall, Armstrong, Paul, O'Conner, Christopher M., Mentz, Robert J.
Gepubliceerd in 2018Text -
20
Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials door Ahmad, Tariq, Miller, P. Elliott, McCullough, Megan, Desai, Nihar R., Riello, Ralph, Psotka, Mitchell, Böhm, Michael, Allen, Larry A., Teerlink, John R., Rosano, Giuseppe M.C., Lindenfeld, Joann
Gepubliceerd in 2019Text